Artificial intelligence and diagnosis and management of tuberculosis disease in children

Purpose of review The literature review is pertinent because diagnosing pediatric tuberculosis (PdTB) remains quite challenging, especially in areas with limited resources, due to complications caused by variable generalized symptoms, paucibacillary characteristics, vague clinical manifestations, and challenges associated with pediatric sputum sample production. Recent developments in artificial intelligence have the potential to enhance the accuracy of diagnoses and the effectiveness of treatments. Recent findings Nineteen published studies between January 2024 and July 2025 were examined, which focused on artificial intelligence driven chest X-ray (CXR) examination and medical prediction. The reviewed studies utilized convolutional neural networks (CNN), transfer learning, and stacked ensemble machine learning (SEML) to achieve sensitivity values ranging from 76.0 to 98.2%, specificity of 70.0 to 98.0%, and area under the curve (AUC) values of as high as 0.98 in AI-CXR diagnosis for the detection of PdTB. Through continuous experiments and use of the AI-CXR triage in Ethiopia (2025), successfully identifying over 30% of patients, while prediction models indicate 82% hepatotoxicity concerns in Nigerian cohorts. Plasma proteomics and exhaled breath analysis are emerging methodologies that exhibit potential; however, pediatric datasets are limited, necessitating multicenter validation. Summary Artificial intelligence enhances the diagnosis and treatment prediction of PdTB in resource-constrained settings. The integration of artificial intelligence with existing diagnostic tools like GeneXpert and telemedicine strategies can significantly improve the efficiency of screening processes. Future research efforts should prioritize the expansion of pediatric datasets and the evaluation of multimodal AI-PdTB approaches.